Global X Genomics & Biotechnology ETF (GNOM) Holdings $9.60 -0.01 (-0.10%) As of 01/17/2025 03:55 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 42 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1NTRANatera$158.36-6.0%5.87%24,9962VCYTVeracyte$40.58-1.3%5.40%91,4523QGENQiagen$46.00+0.2%4.58%70,4624BNTXBioNTech$111.93-0.7%4.51%26,7415TECHBio-Techne$75.83-0.4%4.47%42,7936AAgilent Technologies$147.57+2.0%4.35%22,2987ARWRArrowhead Pharmaceuticals$19.56+2.8%4.28%148,9698SRPTSarepta Therapeutics$118.00+0.8%4.14%22,8319BMRNBioMarin Pharmaceutical$61.53+0.5%4.12%42,41610ILMNIllumina$136.67-0.5%3.97%20,745 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11CRSPCRISPR Therapeutics$40.53+0.6%3.90%64,50412BEAMBeam Therapeutics$23.44+0.2%3.63%100,69313ALNYAlnylam Pharmaceuticals$246.27-1.2%3.44%10,07514LEGNLegend Biotech$32.66+3.9%3.43%67,52215MRNAModerna$34.06+0.9%3.41%55,58416RAREUltragenyx Pharmaceutical$40.00-2.1%3.26%54,26717RNAAvidity Biosciences$28.92+2.2%2.98%65,36318TXG10x Genomics$15.08-0.1%2.90%139,97219Genscript Biotech CorporationN/A2.72%1,471,11820NTLAIntellia Therapeutics$9.50+0.8%2.50%140,22521MYGNMyriad Genetics$12.39-1.0%2.42%122,76322GILDGilead Sciences$91.84+0.2%2.28%17,01623RCKTRocket Pharmaceuticals$10.31+1.0%2.19%117,76224CDNACareDx$21.44-2.8%2.18%69,33225VRTXVertex Pharmaceuticals$422.00+1.2%1.88%3,17326QUREuniQure$14.05-1.1%1.65%62,39227VIRVir Biotechnology$10.11+0.6%1.32%123,89128MRVIMaravai LifeSciences$4.77+4.4%1.31%163,41329PSTXPoseida Therapeutics$9.501.23%89,85830PACBPacific Biosciences of California$1.64+2.5%0.95%360,36131VERVVerve Therapeutics$6.14+0.7%0.76%86,64732FLGTFulgent Genetics$17.10-2.3%0.74%27,40233RGNXREGENXBIO$7.37+3.1%0.71%61,79234ALLOAllogene Therapeutics$1.82-1.1%0.62%191,55335SGMOSangamo Therapeutics$1.09-0.9%0.46%276,14836SANASana Biotechnology$3.16-2.8%0.41%168,90137TSVT2seventy bio$2.61+7.0%0.29%66,69238CRBUCaribou Biosciences$1.53-0.6%0.28%114,10439EDITEditas Medicine$1.22-1.6%0.22%113,08640LYELLyell Immunopharma$0.58+3.0%0.18%190,071Bitcoin to $200K? (Ad)Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. Today, he says there's a much smaller crypto – trading for less than $1 – that's likely to deliver way bigger gains than Bitcoin.This is the #1 crypto you should buy in 2025.41CashN/A0.07%47,66542SCLXScilex$0.45-4.3%0.01%226,071 Geographic ExposureUnited States87.5%Switzerland3.8%Cayman Islands2.6%Currency ExposureUSD77.9%HKD2.6%Sector ExposureHealth Care66.0%Energy0.9%Industry ExposureBiotechnology31.1%Health Care Equipment & Supplies25.3%Health Care Providers & Services7.1%Life Sciences Tools & Services2.6%Renewable Energy0.9%SubIndustry ExposureBiotechnology30.6%Life Sciences Tools & Services25.5%Health Care Services7.1%Health Care Equipment2.4%Renewable Energy Equipment0.9% Related Companies and Tools Related Companies QQMG Holdings HRTS Holdings EBIZ Holdings BLCN Holdings MAGX Holdings SPC Holdings VPN Holdings TARK Holdings MDCP Holdings AGNG Holdings This page (NASDAQ:GNOM) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts